Journal of Bone and Joint Surgery, American Volume最新文献

Background: This prospective cohort study determined the prevalence of intimate partner violence (IPV) across gender groups, investigated timing of disclosures during the standard-of-care follow-up period, and examined if there was an association between IPV and clinical outcomes.

Methods: This study included 314 patients ≥18 years of age presenting with orthopaedic injuries to the fracture clinics at 2 academic hospitals. Participants were asked about experiences with IPV, return to function, and overall health at each routine clinical follow-up. Cox proportional-hazards regression models were used to explore associations between IPV status and return to work, leisure activities, home responsibilities, and overall functioning.

Results: Of the 528 patients approached, 314 provided consent and completed at least the initial visit. Of these, 184 (58.6%) self-identified as women, 126 (40.1%) identified as men, and 3 (1.0%) self-identified as non-binary. Forty-six percent of women reported lifetime experience of IPV, compared with 35% of men and 100% of gender-diverse participants. A smaller proportion of men who disclosed IPV did so at their first visit compared with women, especially with respect to sexual IPV: 6 men (50.0%) compared with 42 women (79.2%). During follow-up, 16 participants (6.7% of 238 who returned to the clinic at least once), including 8 men, 7 women, and 1 gender-diverse participant, disclosed experiencing IPV during their recovery period. Disclosing IPV at any visit was associated with a 45% lower likelihood of returning to a pre-injury level of function with respect to work (hazard ratio [HR], 0.55 [95% confidence interval (CI), 0.33 to 0.91]; p = 0.021) and a 36% lower likelihood of returning to a pre-injury overall level of functioning (HR, 0.64 [95% CI, 0.46 to 0.90]; p = 0.01).

Conclusions: Results showed an unacceptably high prevalence of IPV in all genders. Gender differences in timing of disclosure emphasize the need for tailored approaches in clinical settings and repeated opportunities for IPV disclosure. This study emphasizes the hidden nature of IPV among patients with orthopaedic trauma and its effects on their health and recovery.

Level of evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

Background: Patellofemoral instability is a difficult problem to assess because of its dynamic nature, which is not easily quantified using physical examination techniques. This study aimed to describe and evaluate a novel examination method using stress ultrasonography to quantify patellar instability. The secondary aim was to assess the relationship of stress ultrasonography measurements with clinical and morphologic risk factors for patellar instability.

Methods: Knees with symptomatic patellar instability underwent the ultrasound-assisted patellar glide test. In this test, the patella was translated laterally from its resting position during ultrasound visualization until an endpoint was reached. The medial patellofemoral distance (MPFD) was used to quantify the gap between the medial boundary of the patella and the trochlea, and the difference in MPFD between the resting (unloaded) and loaded conditions was defined as the delta MPFD. Measurements were compared with those in asymptomatic contralateral knees of patients with unilateral instability, asymptomatic knees after patellar stabilization surgery, and control knees. Regression analyses assessed for relationships of MPFD with morphological and clinical risk factors. Receiver operating characteristic (ROC) curve analysis assessed the ability of stress ultrasonography measurements to discriminate between knees with and without symptomatic patellar instability.

Results: Four hundred and seventy-seven knees in 277 patients were included in this study; 173 of the knees had patellar instability (patient age, 24 ± 8 years; 72% female). Delta MPFD was 3 times greater in knees with patellar instability (median, 3.3 mm [95% confidence interval, 3.1 to 3.4 mm]) than in the contralateral asymptomatic (1.1 mm [0.9 to 1.3 mm]), postoperative (1.0 mm [0.8 to 1.2 mm]), and control knees (1.4 mm [1.1 to 1.6 mm]). ROC analysis demonstrated an optimal threshold value for delta MPFD of 2.0 mm, which had an area under the curve (AUC) of 0.97 (0.94 to 0.99), demonstrating excellent discrimination in identifying knees with patellar instability. No relationships of clinical or morphologic risk factors with delta MPFD were found.

Conclusions: A delta MPFD of ≥2 mm on the ultrasound-assisted patellar glide test had an AUC of 0.97 for identifying knees with symptomatic patellar instability, indicating excellent discriminatory ability. Additional studies utilizing this method are recommended to standardize and quantify assessments of patellar instability.

Level of evidence: Diagnostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Background: Rotator cuff (RC) tears are common shoulder injuries that cause pain, dysfunction, and abnormal humeral head translation. Balanced force couples in the transverse and coronal planes help to maintain normal glenohumeral mechanics. Although clinical and biomechanical studies have suggested that compensatory activation of residual RC muscles preserves function, the contribution of individual RC subregions to glenohumeral contact mechanics and humeral head translations across progressively increasing tear sizes remains unclear.

Methods: Eight fresh-frozen male cadaveric shoulders (mean age, 56 years; 6 Caucasian; 2 Black) were dissected to isolate RC muscle subregions, and 4 progressive RC tear models were created: Tear I (supraspinatus [SSP] + superior region of the infraspinatus [ISP]), Tear II (SSP + complete ISP), Tear III (SSP + ISP + superior one-third of the subscapularis [SSC]), and Tear IV (SSP + ISP + superior one-third of the SSC + coracohumeral ligament). Each model underwent 3 loading conditions: loaded (as in the intact state), unloaded (i.e., unloading of the torn regions), and compensatory (i.e., increased loading of the remaining subregions). Humeral head translations and glenohumeral contact force, area, and pressure were measured at 10° of abduction with neutral rotation.

Results: Unloaded conditions significantly increased superior and posterior humeral head translations and reduced contact force and area in most models, particularly in Tears III and IV. Compensatory loading by residual RC subregions reduced superior translation by 34% to 44% and posterior translation by 60% to 68%, restoring the humeral head center to within 0.1 to 1.7 mm of its position in the intact condition. Contact forces and areas partially recovered under compensatory loading; however, contact pressure remained elevated in the largest tear model.

Conclusions: Residual RC subregions can partially restore humeral head centering and glenohumeral contact mechanics in progressive RC tears. However, compensation is limited in advanced tear states, highlighting the potential need for surgical intervention to restore force-couple integrity in the transverse plane.

Clinical relevance: These findings support targeted strengthening of the posterior cuff in patients with partial or early-stage massive RC tears to help maintain joint congruency, minimize abnormal glenohumeral contact mechanics and humeral head translation, and potentially delay the progression to cuff tear arthropathy. Surgical repair, particularly of the SSC, may be required in advanced tears to fully restore force coupling and load distribution.

Background: Surgical hip reduction is an accepted treatment option for infantile developmental dysplasia of the hip (DDH) but may be complicated by the development of osteonecrosis, recently re-termed proximal femoral growth disturbance (PFGD). Since the etiology of PFGD is likely related to compromised vascular supply to the femoral head, the need exists for an intraoperative method of assessing changes in femoral head perfusion prior to irreversible injury. This study sought to utilize contrast-enhanced ultrasound (CEUS) to assess intraoperative changes in perfusion following surgical reduction for infantile DDH, with the ultimate goal of predicting and eventually preventing PFGD.

Methods: In this prospective study, CEUS was performed before and immediately after surgical reduction and spica casting in infants undergoing surgery for DDH between 4 and 18 months of age. Delta projections were used to quantitatively analyze changes in perfusion, and a statistical analysis was performed to assess the relationships between patient factors, including casting position, and changes in epiphyseal perfusion.

Results: The study population of 32 patients included 34 hips, comprising 30 hips of female patients (88.2%) and 4 hips of male patients (11.8%), with a mean age and standard deviation of 9.3 ± 3.3 months. A lower perfusion index following surgical reduction (p = 0.003) was seen in the majority (79.4%) of hips. In the remaining hips, a higher perfusion index was observed following reduction (p = 0.03). The greatest significant decreases in perfusion index were observed in the central region of the femoral head epiphysis (p = 0.002), followed by the peripheral region of the femoral head epiphysis (p = 0.03). Axial abduction was correlated with a post-reduction decrease in perfusion index (r = 0.35; p = 0.04). There was a moderately positive correlation between body mass index (BMI) and a post-reduction change in perfusion index (r = 0.45; p = 0.01).

Conclusions: There was wide variation in post-reduction changes in femoral head perfusion after surgical hip reduction and spica casting for infantile DDH, with a gradient of change across the regions of the femoral head. In addition, BMI and in-cast hip position seemed to influence perfusion changes. With continued analysis of these relationships and longer follow-up from our ongoing prospective investigation, we aim to identify the risk factors for PFGD development.

Level of evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Background: Sex-based disparities remain a major challenge in musculoskeletal medicine. Women and men experience different anterior cruciate ligament (ACL) injury rates and severity, but the causes remain unclear. We hypothesized that cellular differences in human progenitor cells contribute to the higher ACL tear risk observed in females.

Methods: ACL samples were collected from 4 male and 5 female patients undergoing ACL reconstruction surgery. Live cells were collected through flow cytometry and sent for single-cell RNA sequencing. Significantly greater expression in either sex relative to the other was defined as a >25% increase in expression level (log2 fold change > 0.32) and p < 0.05). Subpopulation characterization was performed with immunofluorescence on tissue sections.

Results: We discovered sex-based differences in all of the native cell types within the ACL. In particular, fibroblast progenitor-like (TPPP3+) cells from female patients expressed genes associated with dysregulation and degradation of collagen more highly than progenitor cells from male patients.

Conclusions: These results highlight a ligament progenitor population with a sex-dependent gene expression profile. This work suggests that sex-based differences in stem cell populations may drive differential injury rates and outcomes between male and female patients with musculoskeletal injuries.

Clinical relevance: The differential gene expression among TPPP3+ progenitor-like cells provides a possible target population for studying ligamentous injury and regeneration. Differential expression of collagen and extracellular matrix-related genes provides evidence of specific genes that could be therapeutically targeted to strengthen the ACL and reduce the risk of rupture, particularly in female athletes.

Background: Although clinical guidelines endorse enoxaparin for the prevention of venous thromboembolism in patients with orthopaedic trauma, recent evidence from a large clinical trial has demonstrated that aspirin provides comparable protection against death and pulmonary embolism. This study evaluated the cost-effectiveness of thromboprophylaxis with enoxaparin compared with that with aspirin in patients with orthopaedic trauma from the perspective of the U.S. health-care system.

Methods: The study modeled a hypothetical cohort of adult patients with an operatively treated extremity, pelvic, or acetabular fracture based on data from a recent clinical trial and national databases. We used a decision analysis model to compare 30 mg of enoxaparin with 81 mg of aspirin, administered twice daily in-hospital and prescribed for 21 days after discharge. Health-care costs and quality-adjusted life-years (QALYs) within 1 year after the injury derived from published research and publicly available cost data were based on potential disease states, including death or a combination of pulmonary embolism, proximal deep vein thrombosis, distal deep vein thrombosis, or a bleeding complication. We assessed cost-effectiveness compared with a willingness-to-pay threshold of $150,000 per QALY.

Results: Our model estimated that the 1-year health-care costs among patients prescribed enoxaparin were $35,301, producing 0.6705 QALYs. Aspirin was associated with $35,067 in 1-year health-care costs and 0.6701 QALYs. The overall health-care costs were $234 higher with enoxaparin but yielded only a 0.0004 improvement in QALYs, for an incremental cost-effectiveness ratio for enoxaparin of $635,340 per QALY, indicating that enoxaparin is not cost-effective compared with aspirin. In a sensitivity analysis, the probability of enoxaparin thromboprophylaxis being cost-effective compared with aspirin was 9.8% in 10,000 iterations.

Conclusions: The findings suggest that enoxaparin is not cost-effective relative to aspirin for thromboprophylaxis in patients with orthopaedic trauma. The results support consideration of aspirin as a preferred agent in future guidelines, especially given the consistent patient preference for its oral administration.

Level of evidence: Economic and Decision Analysis Level I. See Instructions for Authors for a complete description of levels of evidence.